Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

被引：4

作者：

Besse, Benjamin ^{[1
]}

Garrido, Pilar ^{[2
]}

Puente, Javier ^{[3
]}

Cortot, Alexis ^{[4
]}

Eugenia Olmedo, Maria ^{[2
]}

Perol, Maurice ^{[5
]}

Gil, Maciej ^{[6
]}

Chao, Grace ^{[7
]}

Shahidi, Javad ^{[8
]}

Bennouna, Jaafar ^{[9
]}

机构：

[1] Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Hosp Univ Ramon Y Cajal, Med Oncol Dept, Madrid, Spain

[3] Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain

[4] Lille Univ Hosp, Thorac Oncol, Lille, France

[5] Ctr Leon Berard, Grp Thorac & Orl, Lyon, France

[6] Eli Lilly, Warsaw, Poland

[7] Eli Lilly & Co, Bridgewater, MA USA

[8] Eli Lilly & Co Bridgewater, Bridgewater, MA USA

[9] Inst Cancerol LOuest, Nantes, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

non-small cell lung cancer; Necitumumab; pembrolizumab;

D O I：

10.1016/j.jtho.2016.11.451

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA09.11

引用

页码：S397 / S397

页数：1

共 50 条

[41] Necitumumab for the treatment of squamous cell non-small cell lung cancer
Brinkmeyer, Jessica K.
Moore, Donald C.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 37 - 41
[42] Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189
Garon, Edward B.
Aerts, Joachim
Kim, Jong Seok
Muehlenbein, Catherine E.
Peterson, Patrick
Rizzo, Maria Teresa
Gadgeel, Shirish M.
LUNG CANCER, 2021, 155 : 53 - 60
[43] Evaluation of thoracic stereotactic body radiation therapy (SBRT) for stage IV non-small cell lung cancer (NSCLC).
Wooten, Charles Eric
Smith, Adam Joel Taylor
Edwards, Jason M.
Arnold, Susanne M.
McGarry, Ronald
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[44] ACUTE MYELOID LEUKEMIA IN A PATIENT TREATED WITH PEMBROLIZUMAB FOR STAGE IV NON-SMALL CELL LUNG CANCER
Ibrahim, Nahla
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 49 - 49
[45] Exploratory analyses of efficacy and safety of pemetrexed (Pem) plus bevacizumab (Bev) and bev alone as maintenance therapy (MT) in patients (Pts) with stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC).
Patel, Jyoti D.
Garon, Edward B.
Govindan, Ramaswamy
Reynolds, Craig H.
Spigel, David R.
Olsen, Mark R.
Hermann, Robert C.
Liu, Jingyi
Guba, Susan C.
Pennella, Eduardo J.
Obasaju, Coleman K.
Bonomi, Philip D.
Socinski, Mark A.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[46] Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)
Gadgeel, Shirish M.
LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : 203 - 222
[47] Induction therapy for non-small cell lung cancer (NSCLC)
Nakamura, H
Furukawa, K
Ikeda, N
Shibuya, H
Tanaka, K
Okunaka, T
Hirano, T
Sakai, M
Saito, M
Konaka, C
Kato, H
XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
[48] A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
Ukena, D
Berg, M
Leutz, M
Zell, L
Schlimmer, P
Sybrecht, GW
LUNG CANCER, 1998, 19 (01) : 31 - 36
[49] Surgery for stage IV non-small cell lung cancer?
Puig, Carlos A.
Wigle, Dennis
JOURNAL OF THORACIC DISEASE, 2020, 12 (04) : 1612 - 1614
[50] Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
Velez, Michel
Arango, Belisario A.
Perez, Cesar A.
Santos, Edgardo S.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 117 - 124

← 1 2 3 4 5 →